All Articles
In August 2017, the FDA approved Lynparza tablets for the maintenance treatment of adults with recurrent epithelial ovarian, fallopian tube, or peritoneal cancer who had a response to platinum-based chemotherapy. Read More ›
On July 17, 2017, the FDA approved Nerlynx (neratinib; from Puma Biotechnology) for long-term adjuvant treatment of early-stage, HER2-positive breast cancer in patients who received previous therapy with Herceptin (trastuzumab). Read More ›
By Ethan Hawes
The majority of people diagnosed with multiple myeloma are age 60 or older; Ethan was only 22. Read about Ethan Hawes’ journey with multiple myeloma, which started with debilitating hip pain when he returned home from studying abroad. Read More ›
Dr. Bruce Gershenhorn explores 3 questions patients should ask after learning they have lung cancer. Knowledge is power. Read More ›
Online communities and message boards are terrific options for patients with cancer and survivors to connect and chat with experts and other patients. Take a look at the role online communities serve for survivors in today’s digital world. Read More ›
“I have become an ally with fellow survivors, and have gained profound personal growth, which has ignited in me a passion to do the things I want to accomplish in life,” says Christine Magnus Moore, RN, BSN. Read More ›
Jason Micheli, a pastor and the author of Cancer is Funny: Keeping Faith in Stage-Serious Chemo, explains his mindset and the difficulties of dealing with uncertainty after a lymphoma diagnosis. Read More ›